Brainstorm Cell Theraputc (BCLI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2018 | 06-2018 | 03-2018 | 12-2017 | 09-2017 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -8,565 | -5,389 | -2,298 | -4,952 | -5,228 |
| Depreciation Amortization | 89 | 56 | 25 | 85 | 57 |
| Accounts receivable | 965 | 295 | N/A | -2,792 | 50 |
| Other Working Capital | -787 | 2,899 | -80 | 1,887 | 5,326 |
| Other Operating Activity | -367 | 68 | 227 | 3,408 | 366 |
| Operating Cash Flow | $-8,665 | $-2,071 | $-2,126 | $-2,364 | $571 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -4,921 | -9,904 | 2,914 | 4,170 | 1,360 |
| PPE Investments | -261 | -260 | -45 | -180 | -118 |
| Purchase Of Investment | -4 | -5 | -5 | -4 | -1 |
| Investing Cash Flow | $-5,186 | $-10,169 | $2,864 | $3,986 | $1,241 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 12,065 | 12,019 | 25 | 314 | 105 |
| Financing Cash Flow | $12,065 | $12,019 | $25 | $314 | $105 |
| Beginning Cash Position | 2,483 | 2,483 | 2,483 | 547 | 547 |
| End Cash Position | 697 | 2,262 | 3,246 | 2,483 | 2,464 |
| Net Cash Flow | $-1,786 | $-221 | $763 | $1,936 | $1,917 |
| Free Cash Flow | |||||
| Operating Cash Flow | -8,665 | -2,071 | -2,126 | -2,364 | 571 |
| Capital Expenditure | -261 | -260 | -45 | -180 | -118 |
| Free Cash Flow | -8,926 | -2,331 | -2,171 | -2,544 | 453 |